UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 703

Sortiert nach

Chemo- and Regioselective Lysine Modification on Native Proteins

Journal of the American Chemical Society, 2018-03, Vol.140 (11), p.4004-4017

2018

Link zum Volltext

Verfügbarkeit prüfen

3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade

Molecules (Basel, Switzerland), 2021-11, Vol.26 (21), p.6755

2021

Link zum Volltext

Verfügbarkeit prüfen

Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents

Nature communications, 2016-10, Vol.7 (1), p.13128-9, Article 13128

2016

Link zum Volltext

Verfügbarkeit prüfen

A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging

Chemical science (Cambridge), 2018, Vol.9 (17), p.4185-4189

2018

Link zum Volltext

Verfügbarkeit prüfen

Thiocoumarins: From the Synthesis to the Biological Applications

Molecules (Basel, Switzerland), 2022-07, Vol.27 (15), p.4901

2022

Link zum Volltext

Verfügbarkeit prüfen

Chemoselective Installation of Amine Bonds on Proteins through Aza-Michael Ligation

Journal of the American Chemical Society, 2017-12, Vol.139 (50), p.18365-18375

2017

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Biological Evaluation of Homogeneous Thiol‐Linked NHC‐Au‐Albumin and ‐Trastuzumab Bioconjugates

Chemistry : a European journal, 2018-08, Vol.24 (47), p.12250-12253

2018

Link zum Volltext

Verfügbarkeit prüfen

Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans -6-Styrylcoumarin

Molecules (Basel, Switzerland), 2022-01, Vol.27 (3), p.928

2022

Link zum Volltext

Verfügbarkeit prüfen

Computer-aided Design of Coumarins for Neurodegenerative Diseases: Trends of the Last Decade

Current topics in medicinal chemistry, 2021-01, Vol.21 (25), p.2245

2021

Link zum Volltext

Verfügbarkeit prüfen

Study of coumarin-resveratrol hybrids as potent antioxidant compounds

Molecules (Basel, Switzerland), 2015-02, Vol.20 (2), p.3290-3308

2015

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents

Molecules (Basel, Switzerland), 2013-01, Vol.18 (2), p.1394-1404

2013

Link zum Volltext

Verfügbarkeit prüfen

Monoamine oxidase inhibitors: ten years of docking studies

Current topics in medicinal chemistry, 2012-10, Vol.12 (20), p.2145

2012

Link zum Volltext

Verfügbarkeit prüfen

Structural Insight of New Butyrylcholinesterase Inhibitors Based on Benzylbenzofuran Scaffold

Pharmaceuticals (Basel, Switzerland), 2022-03, Vol.15 (3), p.304

2022

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of the Anti-Aggregation Activity of a Molecular Chaperone Using a Rationally Designed Post-Translational Modification

ACS central science, 2019-08, Vol.5 (8), p.1417-1424

2019

Link zum Volltext

Verfügbarkeit prüfen

Learning from nature: the role of albumin in drug delivery

Future medicinal chemistry, 2018-05, Vol.10 (9), p.983-985

Matos, Maria J

2018

Link zum Volltext

Verfügbarkeit prüfen

Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofurans

International journal of biological macromolecules, 2020-11, Vol.162, p.774-780

2020

Link zum Volltext

Verfügbarkeit prüfen

Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine‐Selective Protein Modification and Charge Modulation

Angewandte Chemie (International ed.), 2019-05, Vol.58 (20), p.6640-6644

International ed. in English, 2019

Link zum Volltext

Verfügbarkeit prüfen

Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors

Bioorganic chemistry, 2021-03, Vol.108, p.104689-104689, Article 104689

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficient and irreversible antibody-cysteine bioconjugation using carbonylacrylic reagents

Nature protocols, 2019-01, Vol.14 (1), p.86-99

2019

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors

Journal of medicinal chemistry, 2011-10, Vol.54 (20), p.7127-7137

2011

Link zum Volltext

Verfügbarkeit prüfen

New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies

Bioorganic & medicinal chemistry, 2017-03, Vol.25 (5), p.1687-1695

2017

Link zum Volltext

Verfügbarkeit prüfen

3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter?

Bioorganic chemistry, 2020-08, Vol.101, p.103964, Article 103964

2020

Link zum Volltext

Verfügbarkeit prüfen

Coumarin‐Rasagiline Hybrids as Potent and Selective hMAO‐B Inhibitors, Antioxidants, and Neuroprotective Agents

ChemMedChem, 2020-03, Vol.15 (6), p.532-538

2020

Link zum Volltext

Verfügbarkeit prüfen

In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies

Journal of biomolecular structure & dynamics, 2023-12, Vol.41 (22), p.13250-13259

2023

Link zum Volltext

Verfügbarkeit prüfen

7‐Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation

ChemMedChem, 2021-01, Vol.16 (1), p.179-186

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 703

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(629)
Mit Volltextzugriff
(646)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Chemo- and Regioselective Lysine Modification on Native Proteins

3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade

Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents

A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging

Thiocoumarins: From the Synthesis to the Biological Applications

Chemoselective Installation of Amine Bonds on Proteins through Aza-Michael Ligation

Synthesis and Biological Evaluation of Homogeneous Thiol‐Linked NHC‐Au‐Albumin and ‐Trastuzumab Bioconjugates

Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans -6-Styrylcoumarin

Computer-aided Design of Coumarins for Neurodegenerative Diseases: Trends of the Last Decade

Study of coumarin-resveratrol hybrids as potent antioxidant compounds

Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents

Monoamine oxidase inhibitors: ten years of docking studies

Structural Insight of New Butyrylcholinesterase Inhibitors Based on Benzylbenzofuran Scaffold

Enhancement of the Anti-Aggregation Activity of a Molecular Chaperone Using a Rationally Designed Post-Translational Modification

Learning from nature: the role of albumin in drug delivery

Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofurans

Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine‐Selective Protein Modification and Charge Modulation

Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors

Efficient and irreversible antibody-cysteine bioconjugation using carbonylacrylic reagents

Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors

New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies

3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter?

Coumarin‐Rasagiline Hybrids as Potent and Selective hMAO‐B Inhibitors, Antioxidants, and Neuroprotective Agents

In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies

7‐Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation

Suchergebnisse filtern